Read the Market Summary Here @- India Animal Vaccine Market Size Zooming 3.6X at Healthy CAGR of More Than 7% to Surpass USD 4.87 Billion and 376.1 Million Doses by 2030 India Animal Vaccine Market ...
This innovative partnership aims to enhance patient comfort and convenience, providing continuous dopaminergic stimulation (CDS) for Advanced Parkinson's Disease patients through easy-to-administer ...
Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...
Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's ...
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...
Designed as a potential single-injection once-monthly subcutaneous treatment to address the unmet ... a wholly-owned potential first-in-class dual Aß/tau vaccine designed for the treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback